Showing results (151-160 of 360) with videos related to

Sort By:
Pageof 36
British Journal of Pharmacology|May 15, 2003
Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitroMichele Tognetto, Michael R D'Andrea, Marcello Trevisani, et al.
The Journal of Headache and Pain|February 15, 2019
Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraineSimona Sacco, Silvia Benemei, Sabina Cevoli, et al.
Cephalalgia : an International Journal of Headache|December 10, 2024
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraineMarina Romozzi, Ammar Lokhandwala, Catello Vollono, et al.
CNS Spectrums|June 26, 2020
Mental pain and pain-proneness in patients with migraine: results from the PAINMIG cohort-studyFiammetta Cosci, Andrea Svicher, Giovanni Mansueto, et al.
Free Radical Biology & Medicine|January 22, 2025
Characterisation of periorbital mechanical allodynia in the reserpine-induced fibromyalgia model in mice: The role of the Schwann cell TRPA1/NOX1 signalling pathwayEvelyne Silva Brum, Lorenzo Landini, Daniel Souza Monteiro de Araújo, et al.
Expert Review of Neurotherapeutics|December 28, 2017
Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real lifeCristina Tassorelli, Gioacchino Tedeschi, P Sarchielli, et al.
The Journal of Headache and Pain|July 2, 2017
Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centersCristina Tassorelli, Marco Aguggia, Marina De Tommaso, et al.
British Journal of Pharmacology|March 28, 2006
Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airwaysGino Villetti, Marco Bergamaschi, Franco Bassani, et al.
Headache|July 16, 2024
Impact of duration of chronic migraine on long-term effectiveness of monoclonal antibodies targeting the calcitonin gene-related peptide pathway-A real-world studyRaffaele Ornello, Francesca Baldini, Agnese Onofri, et al.
British Journal of Pharmacology|March 19, 2003
Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxinMichela Rigoni, Marcello Trevisani, David Gazzieri, et al.
Pageof 36